JNCCN—Journal of the National Comprehensive Cancer Network– introduced new associate editors, who reflect the journal’s growing focus on original research designed to improve the quality of cancer care delivery, worldwide. The expanding focus on original research is led by editor-in-chief Margaret Tempero, professor of medicine and Director of the UCSF Pancreas Center at UCSF Helen Diller Family Comprehensive Cancer Center.
The Oncologic Drugs Advisory Committee held its first session since President Trump’s inauguration, with a two-day, back-to-back marathon meeting, signaling a return to business at FDA after significant upheaval at the agency.
